Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.
ConditionChronic Idiopathic Urticaria
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University
About this trial
To evaluate the efficacy of Autologous Whole Blood Therapy versus conventional treatment using fourfold dose of antihistamines in Autologus serum skin test (ASST) positive and negative Chronic Idiopathic Urticaria (CIU) patients and suggest its possible mechanism of action.
Eligibility criteria
Qualifiers
None
Disqualifiers
other types of chronic urticaria
Pregnancy
Lactation
Immunocompromised patients
Trial design
Treatments tested in this trial
- Autologous whole blood therapy
- Desloratadine
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov